Skip to main content

Table 1 Follow-up chart of study participants

From: Intermittent preventive treatment: efficacy and safety of sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine plus piperaquine regimens in schoolchildren of the Democratic Republic of Congo: a study protocol for a randomized controlled trial

Timeline in months Baseline 4 8 12
Informed consent X    
Socio-economic and demographic X    X
History (symptoms) X X X X
Examination (clinical) X    X
Temperature X X X X
School achievement X    X
Blood film X X X X
Hemoglobin (hemocontrol) X X X X
Thin and thick smear X X X X
Plasma sample X    X
Filter paper PCR X    X
Stool and urine sample X    X
Malaria treatmentb X X X X
Anthelminthic treatment X Xa Xa X
Adverse events X X X X
Concomitant medications X X X X
  1. aonly albendazole is given to participants. ball participants will receive SP at Month 12 irrespective of the treatment allocation. In lines: we have the timelines (in months) that are displayed as baseline, month 4, month 8 and month 12. In columns are the study tasks that are performed and the parameters that are collected. X means perform this task. Blank cells mean that the specific activity will not be performed at the corresponding timeline.